Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

A. Sarah Walker; Karina Doris Vihta; Owen Gethings; Emma Pritchard; Joel Jones; Thomas House; Iain Bell; John I. Bell; John N. Newton; Jeremy Farrar; Ian Diamond; Ruth Studley; Emma Rourke; Jodie Hay; Susan Hopkins; Derrick Crook; Tim Peto; Philippa C. Matthews; David W. Eyre; Nicole Stoesser; Koen B. Pouwels

doi:10.1056/NEJMc2103227

Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

A. Sarah Walker^*
, Karina Doris Vihta
, Owen Gethings
, Emma Pritchard
, Joel Jones
, Thomas House
, Iain Bell
, John I. Bell
, John N. Newton
, Jeremy Farrar
, Ian Diamond
, Ruth Studley
, Emma Rourke
, Jodie Hay
, Susan Hopkins
, Derrick Crook
, Tim Peto
, Philippa C. Matthews
, David W. Eyre
, Nicole Stoesser

Koen B. Pouwels

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

57 Citations (Scopus)

Original language	English
Pages (from-to)	2582-2585
Number of pages	4
Journal	New England Journal of Medicine
Volume	385
Issue number	27
DOIs	https://doi.org/10.1056/NEJMc2103227
Publication status	Published - 30 Dec 2021

Bibliographical note

Funding Information:
Unit. Dr. Matthews is supported by an intermediate fellowship (110110/Z/15/Z) from Wellcome, and Dr. Eyre is supported by a Robertson Fellowship; both authors are funded by senior fellowship awards from the NIHR Oxford Biomedical Research Centre. Dr. Walker is an NIHR Senior Investigator.

Funding Information:
Supported by the Department of Health and Social Care with in-kind support from the Welsh Government, from the Department of Health on behalf of the Northern Ireland Government, and from the Scottish Government; by a grant (NIHR200915) from the Health Protection Research Unit of the National Institute for Health Research (NIHR) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with the UK Health Security Agency; by the NIHR Oxford Biomedical Research Centre; by the Huo Family Foundation; and by a grant (MC_UU_12023/22) from the Medical Research Council (MRC) UK to the MRC Clinical Trials

Access to Document

10.1056/NEJMc2103227

Cite this

Walker, A. S., Vihta, K. D., Gethings, O., Pritchard, E., Jones, J., House, T., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Studley, R., Rourke, E., Hay, J., Hopkins, S., Crook, D., Peto, T., Matthews, P. C., Eyre, D. W., ... Pouwels, K. B. (2021). Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom. New England Journal of Medicine, 385(27), 2582-2585. https://doi.org/10.1056/NEJMc2103227

@article{00c89f54033348ceae993f862a96f29a,

title = "Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom",

author = "Walker, \{A. Sarah\} and Vihta, \{Karina Doris\} and Owen Gethings and Emma Pritchard and Joel Jones and Thomas House and Iain Bell and Bell, \{John I.\} and Newton, \{John N.\} and Jeremy Farrar and Ian Diamond and Ruth Studley and Emma Rourke and Jodie Hay and Susan Hopkins and Derrick Crook and Tim Peto and Matthews, \{Philippa C.\} and Eyre, \{David W.\} and Nicole Stoesser and Pouwels, \{Koen B.\}",

note = "Funding Information: Unit. Dr. Matthews is supported by an intermediate fellowship (110110/Z/15/Z) from Wellcome, and Dr. Eyre is supported by a Robertson Fellowship; both authors are funded by senior fellowship awards from the NIHR Oxford Biomedical Research Centre. Dr. Walker is an NIHR Senior Investigator. Funding Information: Supported by the Department of Health and Social Care with in-kind support from the Welsh Government, from the Department of Health on behalf of the Northern Ireland Government, and from the Scottish Government; by a grant (NIHR200915) from the Health Protection Research Unit of the National Institute for Health Research (NIHR) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with the UK Health Security Agency; by the NIHR Oxford Biomedical Research Centre; by the Huo Family Foundation; and by a grant (MC\_UU\_12023/22) from the Medical Research Council (MRC) UK to the MRC Clinical Trials",

year = "2021",

month = dec,

day = "30",

doi = "10.1056/NEJMc2103227",

language = "English",

volume = "385",

pages = "2582--2585",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "27",

}

Walker, AS, Vihta, KD, Gethings, O, Pritchard, E, Jones, J, House, T, Bell, I, Bell, JI, Newton, JN, Farrar, J, Diamond, I, Studley, R, Rourke, E, Hay, J, Hopkins, S, Crook, D, Peto, T, Matthews, PC, Eyre, DW, Stoesser, N & Pouwels, KB 2021, 'Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom', New England Journal of Medicine, vol. 385, no. 27, pp. 2582-2585. https://doi.org/10.1056/NEJMc2103227

TY - JOUR

T1 - Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

AU - Walker, A. Sarah

AU - Vihta, Karina Doris

AU - Gethings, Owen

AU - Pritchard, Emma

AU - Jones, Joel

AU - House, Thomas

AU - Bell, Iain

AU - Bell, John I.

AU - Newton, John N.

AU - Farrar, Jeremy

AU - Diamond, Ian

AU - Studley, Ruth

AU - Rourke, Emma

AU - Hay, Jodie

AU - Hopkins, Susan

AU - Crook, Derrick

AU - Peto, Tim

AU - Matthews, Philippa C.

AU - Eyre, David W.

AU - Stoesser, Nicole

AU - Pouwels, Koen B.

N1 - Funding Information: Unit. Dr. Matthews is supported by an intermediate fellowship (110110/Z/15/Z) from Wellcome, and Dr. Eyre is supported by a Robertson Fellowship; both authors are funded by senior fellowship awards from the NIHR Oxford Biomedical Research Centre. Dr. Walker is an NIHR Senior Investigator. Funding Information: Supported by the Department of Health and Social Care with in-kind support from the Welsh Government, from the Department of Health on behalf of the Northern Ireland Government, and from the Scottish Government; by a grant (NIHR200915) from the Health Protection Research Unit of the National Institute for Health Research (NIHR) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with the UK Health Security Agency; by the NIHR Oxford Biomedical Research Centre; by the Huo Family Foundation; and by a grant (MC_UU_12023/22) from the Medical Research Council (MRC) UK to the MRC Clinical Trials

PY - 2021/12/30

Y1 - 2021/12/30

UR - https://www.scopus.com/pages/publications/85122503086

U2 - 10.1056/NEJMc2103227

DO - 10.1056/NEJMc2103227

M3 - Letter

C2 - 34879193

AN - SCOPUS:85122503086

SN - 0028-4793

VL - 385

SP - 2582

EP - 2585

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 27

ER -

Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom

Bibliographical note

Access to Document

Other files and links

Cite this